Prenatal diagnosis after high chance non-invasive prenatal testing for trisomies 21, 18 and 13, chorionic villus sampling or amniocentesis? - Experience at a district general hospital in the United Kingdom

被引：3
|
作者：
Okoror, Collins Ejakhianghe Maximilian [1 ,2 ]
Arora, Suruchi [1 ]
机构：
[1] Royal Berkshire Hosp, Dept Obstet & Gynaecol, Craven Rd, Reading RG1 5AN, England
[2] Royal Berkshire Hosp, Dept Obstet & Gynaecol, Reading RG1 5AN, England
来源：
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X | 2023年 / 19卷
关键词：
Non-invasive prenatal testing (NIPT); Antenatal screening/diagnosis; Chorionic villus sampling (CVS); Amniocentesis; Invasive prenatal testing/diagnosis; Confined placental mosaicism (CPM); CELL-FREE DNA; FREE FETAL DNA; MATERNAL PLASMA; NATIONAL SOCIETY; ANEUPLOIDIES; MOSAICISM; CONFIRMATION; ABNORMALITY; PREGNANCIES; STATEMENT;
D O I：
10.1016/j.eurox.2023.100211
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The non-invasive prenatal testing (NIPT) analyses cell-free DNA (cfDNA) derived from the placental tissue in the maternal circulation. Though highly sensitive and specific, a major limitation is in cases of confined placental mosaicism (CPM). Whether to perform chorionic villus sampling (CVS) or amniocentesis to confirm a positive NIPT result is controversial. One major drawback of CVS is that cytogenetic diagnosis may not always reflect the true chromosomal make-up of the fetus. This work, therefore, proposes the use of amniocentesis in the presence of normal ultrasound findings, and the option of either CVS or amniocentesis when there are abnormal USS findings.
引用
收藏
页数：6
相关论文
共 41 条
  • [21] Non-Invasive Prenatal Testing for the most common aneuploidies (trisomies 21, 18, and 13) using a semiconductor-sequencing platform: a French multicenter pilot study
    da Fonseca, Juliana Pipoli
    El Khattabi, Laila
    Brun, Stephanie
    Chatron, Nicolas
    Gueguen, Paul
    Nectoux, Juliette
    Dumont, Florent
    Schutz, Sacha
    Sorlin, Arthur
    Quere, Manal
    Boudjarane, John
    Guichoux, Erwan
    Bannwarth, Sylvie
    Bonnet, Celine
    Badens, Catherine
    Bolard, Caroline Schluth
    Bardel, Claire
    Lagarde, Arnaud
    Fournier, Amandine Campan
    Letourneur, Franck
    Jonveaux, Philippe
    Paquis-Fluckinger, Veronique
    Vidaud, Michel
    Arveiler, Benoit
    Goossens, Michel
    Rooryck, Caroline
    Sanlaville, Damien
    Dupont, Jean-Michel
    Ferec, Claude
    CHROMOSOME RESEARCH, 2015, 23 : S110 - S111
  • [22] Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform
    Yuan Tian
    Linlin Zhang
    Weifang Tian
    Jinshuang Gao
    Liting Jia
    Shihong Cui
    Molecular Cytogenetics, 11
  • [23] Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform
    Tian, Yuan
    Zhang, Linlin
    Tian, Weifang
    Gao, Jinshuang
    Jia, Liting
    Cui, Shihong
    MOLECULAR CYTOGENETICS, 2018, 11
  • [24] Non-invasive prenatal testing for detection of trisomy 13, 18, 21 and sex chromosome aneuploidies in 8594 cases
    Zheng, Yunyun
    Wan, Shanning
    Dang, Yinghui
    Song, Tingting
    Chen, Biliang
    Zhang, Jianfang
    GINEKOLOGIA POLSKA, 2019, 90 (05) : 270 - 273
  • [25] Non-Invasive Prenatal Genetic Testing (NIPT) Leading to Prenatal Diagnosis of Trisomy 21 Mosaicism and 18q Deletion Syndrome: Two Cases
    Hayata, Kei
    Mishima, Sakurako
    Ohira, Akiko
    Tani, Kazumasa
    Maki, Jota
    Eto, Eriko
    Ogawa, Chikako
    Masuyama, Hisashi
    ACTA MEDICA OKAYAMA, 2021, 75 (06) : 745 - 750
  • [26] Cell-based non-invasive prenatal testing (cbNIPT): an alternative to chorionic villus sampling to confirm diagnosis of unaffected fetuses following preimplantation genetic testing for monogenic disorders (PGT-M)
    Toft, C. L. F.
    Ingerslev, H. J.
    Kesmodel, U. S.
    Hatt, L.
    Singh, R.
    Ravn, K.
    Hestbek, B.
    Christensen, I. B.
    Koelvraa, M.
    Jeppesen, L. D.
    Schelde, P.
    Vogel, I.
    Uldbjerg, N.
    Farlie, R.
    Sommer, S.
    Ostergaard, M. L. V.
    Jensen, A. N.
    Mogensen, H.
    Degn, B.
    Okkels, H.
    Ernst, A.
    Pedersen, I. S.
    HUMAN REPRODUCTION, 2020, 35 : 79 - 79
  • [27] Clinical experience of noninvasive prenatal testing for fetal trisomies 21, 18 and 13 in high and intermediate-risk pregnancies after public combined first trimester screening
    Lund, I. C. B.
    Vestergaard, E. M.
    Lildballe, D.
    Becher, N.
    Petersen, O. B.
    Vogel, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 128 - 129
  • [28] Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases
    Zhang, Yanchun
    Xu, Hongyan
    Zhang, Wen
    Liu, Kaibo
    FRONTIERS IN GENETICS, 2022, 13
  • [29] Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China
    Xiang, Liangcheng
    Zhu, Jun
    Deng, Kui
    Li, Qi
    Tao, Jing
    Li, Mingrong
    Wang, Yanping
    Yuan, Xuelian
    Yao, Yongna
    Li, Xiaohong
    PRENATAL DIAGNOSIS, 2023, 43 (08) : 1036 - 1043
  • [30] Uptake and outcomes of implementing non-invasive prenatal testing (Prenatal Reflex DNA testing) into first-trimester contingent screening protocols for trisomy 21, 18, 13: A study protocol
    Malekzadeh, Reza
    Modaberisaber, Younes
    Farrokhi, Babak
    Hamidian, Yaser
    Ordoubadi, Mohammadreza
    Hantoushzadeh, Sedigheh
    Jamal, Ashraf
    Kobarfard, Farzad
    Saatchi, Mohammad
    Najafipour, Reza
    Soleimani, Zahra
    Soltanghoraee, Haleh
    Sarvestani, Sara Khorami
    Darbandi, Sara
    Darbandi, Mahsa
    Cannarella, Rossella
    Nicolaides, Kypros H.
    Khorshid, Hamid Reza Khorram
    GENE REPORTS, 2024, 35
12345